ArticleWorld journal of microbiology & biotechnology2026
Multi-locus phylogeny and cuticle-degrading enzyme activities of entomopathogenic fungi from forest ecosystems in Northern Thailand.
Article in World journal of microbiology & biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
The escalating demand for sustainable pest management strategies has intensified research interest in entomopathogenic fungi (EPF), particularly regarding their taxonomic diversity and biocontrol potential in tropical ecosystems. However, only a limited number of comprehensive surveys that combine molecular phylogenetics with functional characterization have been conducted in Asia. In the present study, we collected mycosed insect cadavers from forest areas in Chiang Mai Province, northern Thailand. Morphological characteristics and multilocus phylogenetic analysis were conducted to facilitate proper species identification. Fungal isolates were further screened for proteolytic, chitinolytic, and lipolytic activities using a preliminary whole-plate assay. Further, a larval mortality bioassay using the mealworm beetle, Tenebrio molitor, was performed to confirm pathogenicity and assess the insecticidal potential of the fungal isolate under controlled laboratory conditions. In the field, seven insect cadavers infected with six different EPF species were collected. The collected fungal isolations were identified as Beauveria asiatica, B. bassiana, Clonostachys rogersoniana, Cordyceps blackwelliae, two strains of C. tenuipes, and Purpureocillium takamizusanense. For the enzymatic assay, C. tenuipes (MFLUCC 25-0373) has the highest chitinolytic activity, while P. takamizusanense (MFLUCC 25-0376) showed the highest proteolytic activity. In addition, Cl. Rogersoniana (MFLUCC 25-0379), C. tenuipes (MFLUCC 25-0373), and P. takamizusanense (MFLUCC 25-0376) showed higher and similar lipolytic activity. Notably, no single isolate in this study exhibited detectable activity for all three enzymes. Except for B. bassiana (MFLUCC 25-0375) and C. blackwelliae (MFLUCC 25-0377), which showed chitinolytic and proteolytic activity, respectively, all other isolates demonstrated activity for at least two of the three key enzymes. Most fungal isolates induced initial larval mortality by the third day post-exposure; however, virulence levels varied over time. Notably, no clear correlation was observed between enzyme activity and larval virulence, suggesting that fungal pathogenicity is a multifactorial process not merely dependent on extracellular enzymatic activity. Therefore, here, cumulative larval mortality was considered the primary criterion for candidate selection for future biocontrol formulation development, under which B. bassiana (MFLUCC 25-0375) was identified as the most suitable candidate, exhibiting the highest virulence.
Indexed as
Identifiers
42184046What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.